Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedApr 12, 2026
DataAggregated Company Financials
Companies5
  • 7D1.0%
  • 3M-17.8%
  • 1Y24.4%
  • YTD-14.7%

The Biotech industry has been flat over the last week, but Zealand Pharma has lost 3.4%. As for the the longer term, the industry is up 24% over the past 12 months. Earnings are forecast to grow by 2.8% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 12 Apr 2026DKK 145.9bDKK 39.2bDKK 13.9b11.1x10.5x3.7x
Tue, 10 Mar 2026DKK 138.7bDKK 40.1bDKK 15.0b5.8x9.2x3.5x
Thu, 05 Feb 2026DKK 169.7bDKK 40.4bDKK 18.9b6.2x9x4.2x
Sat, 03 Jan 2026DKK 171.7bDKK 40.6bDKK 19.0b6.2x9x4.2x
Mon, 01 Dec 2025DKK 176.9bDKK 40.8bDKK 19.1b5.9x9.3x4.3x
Wed, 29 Oct 2025DKK 166.4bDKK 39.0bDKK 16.8b13x9.9x4.3x
Fri, 26 Sep 2025DKK 164.2bDKK 38.9bDKK 16.8b12.6x9.8x4.2x
Sun, 24 Aug 2025DKK 145.1bDKK 38.8bDKK 16.8b11.1x8.7x3.7x
Tue, 22 Jul 2025DKK 128.1bDKK 27.0bDKK 7.3b11.3x17.5x4.8x
Thu, 19 Jun 2025DKK 128.7bDKK 27.3bDKK 7.5b11.1x17.2x4.7x
Sat, 17 May 2025DKK 125.0bDKK 28.0bDKK 7.9b10.1x15.8x4.5x
Mon, 14 Apr 2025DKK 119.9bDKK 27.3bDKK 7.7b10.7x15.6x4.4x
Wed, 12 Mar 2025DKK 135.5bDKK 27.3bDKK 7.7b11.9x17.6x5x
Fri, 07 Feb 2025DKK 154.4bDKK 26.0bDKK 4.7b15.5x32.9x5.9x
Sun, 05 Jan 2025DKK 165.3bDKK 26.0bDKK 4.7b17.5x35.2x6.4x
Tue, 03 Dec 2024DKK 165.8bDKK 26.0bDKK 4.7b17.3x35.3x6.4x
Thu, 31 Oct 2024DKK 174.6bDKK 25.5bDKK 5.5b21.1x31.9x6.8x
Sat, 28 Sep 2024DKK 180.2bDKK 25.5bDKK 5.5b22.3x32.9x7.1x
Mon, 26 Aug 2024DKK 200.1bDKK 25.5bDKK 5.5b25.7x36.7x7.8x
Wed, 24 Jul 2024DKK 200.7bDKK 24.8bDKK 5.6b18.5x35.6x8.1x
Fri, 21 Jun 2024DKK 168.3bDKK 24.8bDKK 5.6b16.7x29.9x6.8x
Sun, 19 May 2024DKK 183.8bDKK 24.8bDKK 5.6b19.1x32.6x7.4x
Tue, 16 Apr 2024DKK 183.3bDKK 23.9bDKK 5.0b19.4x36.4x7.7x
Thu, 14 Mar 2024DKK 197.1bDKK 23.9bDKK 5.0b20.5x39.2x8.2x
Sat, 10 Feb 2024DKK 169.1bDKK 23.3bDKK 4.2b23x40.6x7.3x
Mon, 08 Jan 2024DKK 177.7bDKK 23.3bDKK 4.2b26x42.7x7.6x
Wed, 06 Dec 2023DKK 178.0bDKK 23.3bDKK 4.2b26x42.8x7.6x
Fri, 03 Nov 2023DKK 158.0bDKK 22.0bDKK 4.7b18.6x33.3x7.2x
Sun, 01 Oct 2023DKK 194.6bDKK 22.0bDKK 4.7b23x41.1x8.8x
Tue, 29 Aug 2023DKK 199.6bDKK 22.0bDKK 4.7b23.6x42.3x9.1x
Thu, 27 Jul 2023DKK 196.1bDKK 19.5bDKK 4.4b34.4x44.5x10x
Sat, 24 Jun 2023DKK 203.3bDKK 19.5bDKK 4.4b42.9x46.1x10.4x
Mon, 22 May 2023DKK 216.2bDKK 19.5bDKK 4.4b44.1x49.1x11.1x
Wed, 19 Apr 2023DKK 212.1bDKK 17.9bDKK 3.5b33.4x60x11.8x
Price to Earnings Ratio

60x


Total Market Cap: DKK 212.1bTotal Earnings: DKK 3.5bTotal Revenue: DKK 17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 29.1x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.5x which is lower than its 3-year average PE of 29.2x.
  • The 3-year average PS ratio of 6.7x is higher than the industry's current PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 58% per year over the last three years.
  • Revenues for these companies have grown 30% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market2.02%
Healthcare1.05%
Biotech0.96%
Biotech0.96%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.79k1.8%
+DKK 1.9b		46.1%PE17.9x
BAVA Bavarian NordicDKK 197.400.9%
+DKK 117.9m		35.3%PE11.1x
BIOPOR BioPortoDKK 0.979.1%
+DKK 40.1m		-27.6%PS11.9x
STRAP Strategic PartnersDKK 645.006.1%
+DKK 1.5m		-32.8%PS87.1x

Latest News

BIOPOR
DKK 0.97
BioPorto
7D
9.1%
1Y
-27.6%
GMAB
DKK 1,790.00
Genmab
7D
1.8%
1Y
46.1%
ZEAL
DKK 287.80
Zealand Pharma
7D
-3.4%
1Y
-32.7%

ZEAL: Obesity Partnership With Roche And AI Hub Will Drive Future Re Rating

Analysts have sharply reduced price targets on Zealand Pharma, with several firms shifting to more neutral ratings and resetting expectations to a range of around DKK 275 to DKK 460. This reflects more conservative views on petrelintide's role in a competitive obesity market.
STRAP
DKK 645.00
Strategic Partners
7D
6.1%
1Y
-32.8%
BAVA
DKK 197.40
Bavarian Nordic
7D
0.9%
1Y
35.3%

BAVA: Expanded Vaccine Pipeline And New Contracts Will Support Higher Future Returns

Analysts have raised their price target on Bavarian Nordic from DKK 244.00 to DKK 280.00. They cite updated assumptions for revenue growth, profit margins, and a lower future P/E multiple that they view as better reflecting the company’s current outlook.